IDEAYA Biosciences (IDYA) EPS (Basic) (2018 - 2026)
IDEAYA Biosciences' (IDYA) quarterly EPS (Basic) came in at -$1.11 in Q1 2026, down 35.37% year-on-year from -$1.72 in Q1 2025, and down 18.09% quarter-over-quarter from -$0.94 in Q4 2025.
IDEAYA Biosciences (IDYA) EPS (Basic) (2018 - 2026) Analysis & Trends
IDEAYA Biosciences has disclosed EPS (Basic) across 9 years of filings, most recently posting -$1.11 for Q1 2026.
- EPS (Basic) for Q1 2026 came in at -$1.11, down 35.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.58 (up 56.71% YoY), and the FY2025 annual result was -$1.28, up 61.9% from the prior year.
- EPS (Basic) came in at -$1.11 for Q1 2026 at IDEAYA Biosciences, down from -$0.94 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $1.35 in Q3 2025 to a low of -$1.55 in Q4 2024.
- The 5-year median for EPS (Basic) is -$0.54 (2022), against an average of -$0.54.
- Across the five-year window, EPS (Basic) plunged 1250.0% in 2023 and surged 325.0% in 2025, its largest moves.
- IDEAYA Biosciences' EPS (Basic) stood at -$0.54 in 2022, then increased by 3.7% to -$0.52 in 2023, then sank by 198.08% to -$1.55 in 2024, then soared by 39.35% to -$0.94 in 2025, then decreased by 18.09% to -$1.11 in 2026.
- The last three EPS (Basic) figures came in at -$1.11 (Q1 2026), -$0.94 (Q4 2025), and $1.35 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -0.68 |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 3.06 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 0.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 0.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 0.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 0.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 4.06 |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -0.06 |
| 10 | IDEAYA Biosciences | 2.78 Bn | 2.10 Bn | - | -1.11 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.11 |
| Dec 31, 2025 | -0.94 |
| Sep 30, 2025 | 1.35 |
| Jun 30, 2025 | -0.88 |
| Mar 31, 2025 | -0.82 |
| Dec 31, 2024 | -1.55 |
| Sep 30, 2024 | -0.60 |
| Jun 30, 2024 | -0.68 |
| Mar 31, 2024 | -0.53 |
| Dec 31, 2023 | -0.52 |
| Sep 30, 2023 | -0.46 |
| Jun 30, 2023 | -0.50 |
| Mar 31, 2023 | -0.49 |
| Dec 31, 2022 | -0.54 |
| Sep 30, 2022 | 0.04 |
| Jun 30, 2022 | -0.57 |
| Mar 31, 2022 | -0.36 |
| Dec 31, 2021 | -0.49 |
| Sep 30, 2021 | -0.31 |
| Jun 30, 2021 | -0.33 |